MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • MDS Virtual Congress 2021

    Prevalence of Suicidal Ideation and Associated Clinical Features in Lewy Body Dementia

    K. Moore, M. Armstrong, C. Jacobson, N. Gamez, B. Patel, J. Sullivan (Gainesville, USA)

    Objective: The goal of this study was to identify the prevalence of suicidal ideation (SI) in Lewy body dementia (LBD) and the factors associated with…
  • MDS Virtual Congress 2021

    Association between emotional/cognitive factors and postural control in individuals with Parkinson’s disease and freezing of gait

    CN. de Oliveira, ACL. de Lima-Pardini, C. Souza, R. Marquesini, LA. Teixeira, CS. Silva-Batista, DB. Coelho (Sp, Brazil)

    Objective: To investigate the association between emotional/cognitive factors and the parameters of postural control of patients with Parkinson’s disease (PD) and freezing of gait (FoG).…
  • MDS Virtual Congress 2021

    Changes in brain functional connectivity after cognitive behavioral therapy for anxiety in Parkinson’s disease: a longitudinal MRI study.

    G. Carey, R. Lopes, A. Moonen, K. Dujardin, A. Leentjens (Lille, France)

    Objective: To identify changes in brain functional connectivity (FC) after Cognitive Behavioral Therapy (CBT) for anxiety in patients with Parkinson’s disease (PD). Background: Recently we…
  • MDS Virtual Congress 2021

    Anxiety and depression in patients with Parkinson’s disease selected for magnetic resonance-guided focused ultrasound thalamotomy.

    O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, I. Buzaev, A. Saveliev, N. Mukhamadeeva, G. Akhmadeeva (Ufa, Russian Federation)

    Objective: To assess the severity of anxiety and depression in patients selected for treatment with the magnetic resonance-guided focused ultrasound thalamotomy (MRgFUS TT) before the…
  • MDS Virtual Congress 2021

    THE ASSOCIATION OF ANXIETY AND DEPRESSION WITH TREMORS IN PARKINSON’S DISEASE PATIENTS

    F. Susanti, C. Arina, H. Hutagalung (Medan, Indonesia)

    Objective: To determine the relation between anxiety and depression with tremors in patients with PD so that it can be possible to detect the symptoms…
  • MDS Virtual Congress 2021

    Effect of COVID-19 stressors on mental health and quality of life in Parkinson’s disease

    L. Dommershuijsen, A. Heide, E. Berg, J. Labrecque, M K. Ikram, M A. Ikram, B. Bloem, R. Helmich, S. Darweesh (Nijmegen, Netherlands)

    Objective: To investigate subgroup differences in the effect of COVID-19 stressors on mental health and quality of life in people with Parkinson’s disease. Background: In…
  • MDS Virtual Congress 2021

    The fear of progression of Parkinson’s Disease

    S. Mayer, E. Tekampe, A. Frank, T. Feige, H. Reichmann, B. Falkenburger (Dresden, Germany)

    Objective: Determine fear of progression (FoP) and its influencing factors in Parkinson's disease (PD) patients to alleviate the psychosocial distress it induces. Background: PD patients…
  • MDS Virtual Congress 2020

    Differential burden of comorbidities for Huntington’s Disease, Parkinson’s Disease and the general population for patients and care partners in the US

    A. Exuzides, J. Matos, B. Ricker, D. Bega (South San Francisco, CA, USA)

    Objective: Describe the comorbidity burden for patients (pt) and care partners (cp) of Huntington’s Disease (HD), Parkinson’s Disease (PD) and the general population (GP) Background:…
  • MDS Virtual Congress 2020

    Profiling Atypical Anxiety in Parkinson’s Disease

    E. Forbes, G. Byrne, J. O'Sullivan, J. Yang, N. Dissanayaka (St Lucia, Australia)

    Objective: We aimed to identify the demographic, psychiatric, clinical and cognitive characteristics associated with Anxiety not otherwise specified (NOS) in persons with Parkinson’s disease (PWP).…
  • MDS Virtual Congress 2020

    Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate features of NMS in PwHD of Tomsk region. Background: Patients with Huntington's disease(PwHD) can complain of other non-motor symptoms(NMS)…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley